Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Cattani

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Clinical Genitourinary Cancer|February 14, 2017
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy ApproachGiulia Marvaso, Barbara A Jereczek-Fossa, Giulia Riva, et al.
Journal of Contemporary Brachytherapy|June 14, 2021
Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: a case reportAndrea Vavassori, Elisabetta Pennacchioli, Matteo Augugliaro, et al.
La Radiologia Medica|January 27, 2024
Post-operative KEloids iRradiation (POKER): does the surgery/high-dose interventional radiotherapy association make a winning hand?Jessica Franzetti, Stefano Durante, Federico Mastroleo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
Tumori|December 17, 2020
COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, ItalyGiulia Corrao, Luca Bergamaschi, Mattia Zaffaroni, et al.
Medical Oncology (Northwood, London, England)|May 12, 2018
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approachGiulia Marvaso, Giulia Riva, Delia Ciardo, et al.
Critical Reviews in Oncology/Hematology|September 8, 2023
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literatureGaia Piperno, Annamaria Ferrari, Stefania Volpe, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapyBarbara A Jereczek-Fossa, Dario Zerini, Cristiana Fodor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2018
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancerMaddalena Mambretti, Chiara RomanĂ², Giulia Marvaso, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Clinical Genitourinary Cancer|February 14, 2017
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy ApproachGiulia Marvaso, Barbara A Jereczek-Fossa, Giulia Riva, et al.
Journal of Contemporary Brachytherapy|June 14, 2021
Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: a case reportAndrea Vavassori, Elisabetta Pennacchioli, Matteo Augugliaro, et al.
La Radiologia Medica|January 27, 2024
Post-operative KEloids iRradiation (POKER): does the surgery/high-dose interventional radiotherapy association make a winning hand?Jessica Franzetti, Stefano Durante, Federico Mastroleo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
Tumori|December 17, 2020
COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, ItalyGiulia Corrao, Luca Bergamaschi, Mattia Zaffaroni, et al.
Medical Oncology (Northwood, London, England)|May 12, 2018
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approachGiulia Marvaso, Giulia Riva, Delia Ciardo, et al.
Critical Reviews in Oncology/Hematology|September 8, 2023
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literatureGaia Piperno, Annamaria Ferrari, Stefania Volpe, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2010
Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapyBarbara A Jereczek-Fossa, Dario Zerini, Cristiana Fodor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2018
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancerMaddalena Mambretti, Chiara RomanĂ², Giulia Marvaso, et al.
Pageof 13